Clinical Trials Intelligence — ClinicalTrials.gov + AI
Pricing
from $66.00 / 1,000 query analyzeds
Clinical Trials Intelligence — ClinicalTrials.gov + AI
Search clinical trials from the official ClinicalTrials.gov registry. Give it conditions, drugs or keywords; get back trial status, phases, sponsors and eligibility.
Pricing
from $66.00 / 1,000 query analyzeds
Rating
0.0
(0)
Developer
Fredrik Hansson
Maintained by CommunityActor stats
0
Bookmarked
2
Total users
1
Monthly active users
12 hours ago
Last modified
Categories
Features
Share
Turn any drug, disease or sponsor into a read on the clinical pipeline. Give it a condition (glioblastoma), a drug (semaglutide) or a company (Moderna) and this Actor searches the official ClinicalTrials.gov registry, pulls every matching trial — phase, status, enrollment, sponsor, interventions — and uses OpenAI to summarise the research landscape: who's leading, where the pipeline sits, which trials matter, and what's emerging.
You bring a search term. It hands back a structured trial table plus an analyst's one-page read.
The flow
1. You give a query 2. ClinicalTrials.gov API v2 3. Get trials + an AI landscapecondition · drug · sponsor → (official registry, free, → phases · status · sponsors ·· keyword no key) enrollment · AI summary
- You give one or more queries — conditions, drugs, sponsors or keywords.
- The Actor queries ClinicalTrials.gov (the official U.S. registry) via its public v2 API, sorted by most-recently-updated, optionally filtered by recruitment status.
- You get back one record per trial, plus a landscape record per query with aggregate metrics and an AI read of the research field.
What you get per query
For every query the Actor:
- Pulls matching trials from ClinicalTrials.gov (up to
maxTrialsPerQuery), each mapped to:nctId,title,overallStatus,phases,studyType,enrollment,leadSponsor,conditions,interventions,startDate,completionDate, and a directurl. - Aggregates the set into
totalTrials(registry-wide count),phaseDistribution,statusDistribution,topSponsorsandrecruitingCount. - Runs one AI pass (OpenAI
gpt-4o-mini, a fast and low-cost model) over the trial set to produce:landscapeSummary— 2-3 sentences on the overall state of research for the query.activePhaseFocus— one sentence on where the pipeline sits across phases.leadingSponsors— the most active sponsors.emergingInterventions— drug / approach names seen across the trials.notableTrials— 3-6 standout trials, each with{ nctId, title, phase, sponsor, why }.signalForInvestors— one neutral, grounded sentence on research momentum.
The AI is grounded only in the trials pulled — it never invents NCT ids, sponsors or phases.
Not medical or financial advice. This Actor surfaces and summarises public registry data for research and business-intelligence purposes. Nothing it outputs is clinical guidance or an investment recommendation.
Three ways people use it
- Pharma / biotech competitive intelligence — track a competitor's drug pipeline, watch a disease area fill with trials, and see which sponsors own which phases. A living clinical trials API feed for your BD and strategy teams, built on ClinicalTrials.gov.
- Investor / BD due diligence — before a deal or a thesis, pull every trial for an asset or an indication, read the phase mix and the enrollment, and get a grounded landscape summary — biotech intelligence without a Bloomberg terminal.
- Clinical research monitoring — CROs, sites and med-affairs teams run standing trial monitoring on conditions and interventions to catch new recruiting studies, terminations and completions the moment the registry updates.
Keywords this covers: clinical trials API, ClinicalTrials.gov, drug pipeline, biotech intelligence, trial monitoring.
Input
| Field | Type | Notes |
|---|---|---|
queries | array | Required. Conditions, drugs, sponsors or keywords. One per line. |
statusFilter | array | Optional. Only return trials in these statuses: RECRUITING, ACTIVE_NOT_RECRUITING, COMPLETED, TERMINATED. Omit for all. |
maxTrialsPerQuery | integer | Trials to pull per query. Default 25. |
maxResults | integer | Cap how many queries to process. Default 100. |
maxConcurrency | integer | Queries processed in parallel. Default 3. |
model | string | Override the OpenAI model. Default gpt-4o-mini. |
Minimal input example
{"queries": ["glioblastoma", "semaglutide", "Moderna"],"maxTrialsPerQuery": 25}
Output example
A trial record (one per trial):
{"query": "glioblastoma","recordType": "trial","nctId": "NCT07862647","title": "TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma","overallStatus": "RECRUITING","phases": ["PHASE1"],"studyType": "INTERVENTIONAL","enrollment": 30,"leadSponsor": "Alpheus Medical, Inc.","conditions": ["Glioblastoma", "GBM", "Butterfly GBM"],"interventions": [{ "type": "DRUG", "name": "5-ALA" },{ "type": "DEVICE", "name": "LIDU ultrasound" }],"startDate": "2026-10-29","completionDate": "2028-03-30","url": "https://clinicaltrials.gov/study/NCT07862647"}
A landscape record (one per query):
{"query": "glioblastoma","recordType": "landscape","totalTrials": 2468,"phaseDistribution": { "PHASE1": 9, "PHASE2": 11, "PHASE3": 2, "NA": 3 },"statusDistribution": { "RECRUITING": 14, "COMPLETED": 7, "TERMINATED": 1 },"topSponsors": [{ "name": "National Cancer Institute (NCI)", "count": 3 },{ "name": "Alpheus Medical, Inc.", "count": 1 }],"recruitingCount": 14,"landscapeSummary": "Glioblastoma research remains highly active, dominated by early-phase interventional trials testing novel drug-device and immunotherapy combinations alongside standard temozolomide + radiotherapy.","activePhaseFocus": "The pipeline sits mostly in Phase 1/2, with few Phase 3 confirmatory studies.","leadingSponsors": ["National Cancer Institute (NCI)", "Alpheus Medical, Inc."],"emergingInterventions": ["5-ALA sonodynamic therapy", "CAR-T", "oncolytic virus"],"notableTrials": [{ "nctId": "NCT07862647", "title": "TMZ + RT + 5-ALA + LIDU SDT", "phase": "PHASE1", "sponsor": "Alpheus Medical, Inc.", "why": "Novel sonodynamic drug-device approach for inoperable butterfly GBM." }],"signalForInvestors": "Momentum is concentrated in early-phase novel modalities rather than late-stage confirmatory trials; not medical or financial advice."}
Pay-per-event pricing
This Actor uses pay-per-event billing with a single event:
| Event | Charged when | Price |
|---|---|---|
query-analyzed | Once per condition/drug/sponsor searched across ClinicalTrials.gov and summarized with AI. | $0.15 |
The Actor logs its OpenAI token usage and the estimated AI cost at the end of every run, so the event price always stays safely above the model cost.
Data source
Data comes from the official ClinicalTrials.gov registry via its public API v2 — a free, U.S. National Library of Medicine service listing publicly and privately supported clinical studies worldwide. No registry key is required.
Setup
The AI layer calls the OpenAI API. Set the environment variable / secret OPENAI_API_KEY on the Actor. Without it, the run stops before processing — the AI landscape read is core to the output.
Use it from an AI agent (Apify MCP server)
This Actor is available through the Apify MCP server, so AI agents (Claude, ChatGPT, or anything that speaks MCP) can call it as a tool — hand it a list of queries, and read back the trials and landscape — with no custom integration code.
Run it locally
npm install# put your input in storage/key_value_stores/default/INPUT.jsonexport OPENAI_API_KEY=sk-...apify run -p
Related actors
- Research Paper Intelligence — Search and summarise academic papers with AI.
- SEC Filings Extractor — Pull structured data from SEC filings.
- Google News Scraper — Track news coverage across any topic or company.
- AI Company Enrichment — Turn domains into structured company profiles with AI.
Part of the No Niner toolkit — no-code web scraping, enrichment & AI data tools, all pay-per-use. Browse the full set at noniner.io.